<DOC>
	<DOCNO>NCT00230204</DOCNO>
	<brief_summary>The purpose investigation ass prevalence infectious disease seropositivity ( toxoplasmosis , rubella , cytomegalovirus [ CMV ] ) , herpes simplex virus type 1 ( HSV-1 ) herpes simplex virus type 2 ( HSV-2 ) , syphilis , Epstein-Barr virus H. pylorus group patient present specific autoimmune disease ( rheumatoid arthritis [ RA ] , undifferentiated connective tissue disorder [ UCTD ] , Sjogren , antiphospholipid syndrome - APS , vasculitides , systemic lupus erythematosus [ SLE ] , polymyositis , Hashimoto , multiple sclerosis , primary biliary cirrhosis [ PBC ] , etc . ) , use BioPlex 2200 complementary EIA kit compare matched control ( age , sex ethnicity ) .</brief_summary>
	<brief_title>Infections Autoimmunity : Autobodies Screening Multiple Sclerosis</brief_title>
	<detailed_description>The purpose investigation ass prevalence infectious disease seropositivity ( toxoplasmosis , rubella , cytomegalovirus [ CMV ] ) , herpes simplex virus type 1 ( HSV-1 ) herpes simplex virus type 2 ( HSV-2 ) , syphilis , Epstein-Barr virus H. pylorus group patient present specific autoimmune disease ( RA , UCTD , Sjogren , antiphospholipid syndrome - APS , vasculitides , SLE , polymyositis , Hashimoto , multiple sclerosis , PBC , etc . ) , use BioPlex 2200 complementary EIA kit compare matched control ( age , sex ethnicity ) . We assess Center 100 patient multiple sclerosis antibody profile different infectious agent . Comparative assessment perform normal matched subject .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Definite multiple sclerosis Intravenous immune globulin ( IVIg ) treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Antibodies</keyword>
	<keyword>Serum</keyword>
	<keyword>Infectious agent</keyword>
	<keyword>Immunoglobulin G</keyword>
	<keyword>Immunoglobulin M</keyword>
</DOC>